Australia markets close in 1 hour 8 minutes

Tempest Therapeutics, Inc. (TPST)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5400-0.0800 (-2.21%)
At close: 04:00PM EDT
3.5100 -0.03 (-0.85%)
After hours: 07:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 79.09M
Enterprise value 60.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.95
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.19

Trading information

Stock price history

Beta (5Y monthly) -2.83
52-week change 376.59%
S&P500 52-week change 321.33%
52-week high 39.7700
52-week low 30.1700
50-day moving average 33.6955
200-day moving average 32.9399

Share statistics

Avg vol (3-month) 3946.48k
Avg vol (10-day) 3365.3k
Shares outstanding 522.22M
Implied shares outstanding 622.22M
Float 817.78M
% held by insiders 10.06%
% held by institutions 129.04%
Shares short (15 Apr 2024) 41.13M
Short ratio (15 Apr 2024) 40.64
Short % of float (15 Apr 2024) 46.30%
Short % of shares outstanding (15 Apr 2024) 45.07%
Shares short (prior month 15 Mar 2024) 4766.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 Dec 2018
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 328 June 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.31%
Return on equity (ttm)-131.42%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.78M
Net income avi to common (ttm)-29.49M
Diluted EPS (ttm)-1.9100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)39.23M
Total cash per share (mrq)1.77
Total debt (mrq)20.66M
Total debt/equity (mrq)77.18%
Current ratio (mrq)4.29
Book value per share (mrq)1.21

Cash flow statement

Operating cash flow (ttm)-27.36M
Levered free cash flow (ttm)-17.47M